Liu Zhiming is the eighth frontline health-care worker to die from COVID-19, and hundreds more have been infected.

The Harvard Medical School researcher’s work on the genetic basis of protein coding and production led him to make groundbreaking discoveries in immunology, molecular biology, and cancer genetics.

In the first clinical study of its kind in the US, researchers used CRISPR to modify CAR T cells to make them more potent against cancer, but the clinical benefits are unknown.

The genetically modified bacteria spark an RNAi response in the parasite that leads to self-destruction—and perhaps a path to combatting colony collapse disorder.

Havran described gamma-delta T cells’ direct function in epithelial repair.

This previously unknown mechanism for spotting foreign genetic material in the cytoplasm launches antiviral defenses even when the well-known immune mediator STING is absent.

In mice, the fight-or-flight response overactivates the cells, causing a drop in their numbers, which leads to loss of hair color.

In mice, a group of nasal epithelial cells called brush cells release pro-inflammatory signals in response to allergens.

The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.